These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2967189)

  • 1. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 8-OH-DPAT elicits gnawing, and eating of solid but not liquid foods.
    Fletcher PJ
    Psychopharmacology (Berl); 1987; 92(2):192-5. PubMed ID: 2955445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat.
    Gradin K; Pettersson A; Hedner T; Persson B
    J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding responses to a high dose of 8-OH-DPAT in young and adult rats: influence of food texture.
    Chaouloff F; Serrurrier B; Mérino D; Laude D; Elghozi JL
    Eur J Pharmacol; 1988 Jul; 151(2):267-73. PubMed ID: 2458945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Brain Res Bull; 1985 Oct; 15(4):377-84. PubMed ID: 2933126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in monkeys.
    Mizuta E; Yamaguchi M; Kuno S
    Eur J Pharmacol; 1990 Mar; 178(1):125-7. PubMed ID: 2139614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2-(di-n-propylamino)tetralin, a selective serotonin1A receptor agonist, reduces the immobility of rats in the forced swimming test by acting on the nucleus raphe dorsalis.
    Cervo L; Grignaschi G; Samanin R
    Eur J Pharmacol; 1988 Dec; 158(1-2):53-9. PubMed ID: 2975608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the adrenal gland in the metabolic and cardiovascular effects of 8-OH-DPAT in the rat.
    Bouhelal R; Mir AK
    Eur J Pharmacol; 1990 May; 181(1-2):89-95. PubMed ID: 2143731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT1A agonist 8-OH-DPAT increases consumption of palatable wet mash and liquid diets in the rat.
    Dourish CT; Cooper SJ; Gilbert F; Coughlan J; Iversen SD
    Psychopharmacology (Berl); 1988; 94(1):58-63. PubMed ID: 2964672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.
    Johansson CE; Meyerson BJ; Höglund AU
    Eur J Pharmacol; 1990 Mar; 178(1):1-9. PubMed ID: 2139613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.